Boeing and Drake State Community & Technical College will, on Wednesday, June 17, announce a new technical apprenticeship ...

Python stays far ahead after another dip; C holds second, Java retakes third from C++, and R rises to eighth as SQL slips, with Delphi steady in tenth. May’s TIOBE Index has one of those charts that ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer from ...

Designed from the ground up as an electric model, the C400 has a relatively roomy interior, 800-volt DC fast charging, and a driving range that could be in excess of 470 miles. It also takes advantage ...

I need another USB-C charger like I need a hole in my head. And as it turns out, I apparently needed another seven holes in my head. Yes, no lie, in the last two weeks I spent my own cash on seven new ...

What are the current dangers in mobile technology and what are the strategies to keep yourself protected? Join host Steve Ragan from the show floor at RSA 2018, where he talks with Will LaSala, ...

Washington — President Trump ordered military strikes on Iran early Saturday, Feb. 28, after pressing the country to curtail its nuclear program, grappling with an issue that has vexed presidents from ...

The U.S. Navy has created a program office charged with developing Collaborative Combat Aircraft (CCA) for the service, as it follows work other services have done. Naval Air Systems Command (NAVAIR) ...

The AHRQ systematic review included 48 RCTs and two retrospective cohort studies. Lung cancer and mesothelioma were the most commonly addressed types of cancer. Nonpharmacologic interventions such as ...

Send a note to Doug Wintemute, Kara Coleman Fields and our other editors. We read every email. By submitting this form, you agree to allow us to collect, store, and potentially publish your provided ...

Patients with previously untreated, locally advanced, unresectable or metastatic triple-negative breast cancer who are not candidates for inhibitors of programmed cell death protein 1 (PD-1) or ...